Proposed Institutional Guidelines for Managing Hypertension in Patients with
Stroke Based on AHA/ASA Guidelines
|
Ischemic Stroke, No Reperfusion Therapy |
|
|
BP Level |
·
SBP > 220 mm Hg or DBP>120 mm Hg |
|
Target BP |
·
Reduce BP by 15% - 25% within 24 hours |
|
Recommended IV antihypertensive options |
·
Nicardipine 5 mg/hr; titrate up by 2.5 mg/hr
every 5-15 minutes to a maximum of 15 mg/hr
until desired BP achieved.
·
Labetolol, 10 mg followed by continuous infusion
at 2-8 mg/min
·
Consider nitroprusside if resistant.
Start at 0.3 mcg/kg/min and titrate
slowly. |
|
Ischemic Stroke with Reperfusion Therapy |
|
|
BP Level |
·
SBP > 185 mmHg or DBP > 110 mmHg |
|
Target BP |
·
SBP > 185 mmHg or DBP > 110 mmHg |
|
Recommended IV antihypertensive options |
·
Nicardipine 5 mg/hr; titrate up by 2.5 mg/hr
every 5-15 minutes to a maximum of 15 mg/hr
until desired BP achieved.
·
Labetolol, 10 mg followed by continuous infusion
at 2-8 mg/min
·
Other agents (hydralazine, enalapril) when
appropriate |
|
Hemorrhage Stroke with ICH |
|
|
BP Level |
·
SBP > 200 mmHg or MAP > 150 mmHg: Aggressive
reduction with continuous IV therapy
·
If increased ICP suspected and SBP > 180 mm Hg
or MAP > 130 mmHg: Intermittent or
continuous IV therapy while maintaining CPP at ≥
60 mmHg
·
SBP > 180 mmHg or MAP > 130 mmHg and no evidence
of elevated ICP: Consider intermittent or
continuous IV therapy to achieve moderate BP
reduction |
|
Target BP |
·
BP < 160/90 mm Hg or MAP < 110 mmHg |
|
Recommended IV antihypertensive options |
·
Nicardipine or Labetolol |
|
SAH |
|
|
BP Level |
·
Unclear
· One
prehospital study suggested SBP < 160 mmHg |
|
Target BP |
·
Unclear |
|
Recommended IV antihypertensive options |
·
Administer short acting continuous intravenous
infusions of Nicardipine, Labetolol, Esmolol |